US Patent 7589193 C-aryl glucoside SGLT2 inhibitors and method

Patent 7589193 was granted and assigned to Bristol-Myers Squibb on September, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

75891930

Patent Inventor Names

Wei Meng0

William Washburn0

Date of Patent

September 15, 2009

Patent Application Number

112336170

Date Filed

September 23, 2005

Patent Citations Received

‌

US Patent 12115179 Pharmaceutical composition, methods for treating and uses thereof

‌

US Patent 11833166 Pharmaceutical composition, methods for treating and uses thereof

‌

US Patent 11918596 Pharmaceutical composition, methods for treating and uses thereof

Patent Primary Examiner

‌

Shaojia Anna Jiang

Patent abstract

A compound of the formula I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7589193 C-aryl glucoside SGLT2 inhibitors and method

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API